A Phase II Study of PD-1 Antibody Plus Neoadjuvant Chemotherapy for Advanced-stage Ovarian Cancer (Z2HOC-01)
Latest Information Update: 30 Mar 2021
At a glance
- Drugs Tislelizumab (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Adenocarcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 30 Mar 2021 New trial record